Revenue | ₹102.70Cr |
Net Profits | ₹5.33Cr |
Net Profit Margins | 5.19% |
Fredun Pharmaceuticals Ltd’s revenue jumped 18.03% since last year same period to ₹102.70Cr in the Q3 2024-2025. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated -4.33% fall in its revenue since last 3-months.
Fredun Pharmaceuticals Ltd’s net profit jumped 26.3% since last year same period to ₹5.33Cr in the Q3 2024-2025. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 24.82% jump in its net profits since last 3-months.
Fredun Pharmaceuticals Ltd’s net profit margin jumped 7.01% since last year same period to 5.19% in the Q3 2024-2025. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 30.48% jump in its net profit margins since last 3-months.
The revenue for Fredun Pharmaceuticals Ltd in the Q3 results 2024 was ₹102.70Cr.
The net profit for Fredun Pharmaceuticals Ltd in the Q3 results 2024 was ₹5.33Cr.
The net profit margin for Fredun Pharmaceuticals Ltd in the Q3 results 2024 was 5.19%.
The revenue for Fredun Pharmaceuticals Ltd in the Q3 results 2023 was ₹87.01Cr.
The net profit for Fredun Pharmaceuticals Ltd in the Q3 results 2023 was ₹4.22Cr.
The net profit margin for Fredun Pharmaceuticals Ltd in the Q3 results 2023 was 4.85%.